Correlation Between Hyundai Mobis and Celltrion Pharm

Can any of the company-specific risk be diversified away by investing in both Hyundai Mobis and Celltrion Pharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hyundai Mobis and Celltrion Pharm into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Hyundai Mobis and Celltrion Pharm, you can compare the effects of market volatilities on Hyundai Mobis and Celltrion Pharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hyundai Mobis with a short position of Celltrion Pharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hyundai Mobis and Celltrion Pharm.

Diversification Opportunities for Hyundai Mobis and Celltrion Pharm

-0.74

Correlation Coefficient

Hyundai Mobis  Celltrion Pharm

Pay attention - limited upside

The 3 months correlation between Hyundai and Celltrion is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding Hyundai Mobis and Celltrion Pharm in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Celltrion Pharm and Hyundai Mobis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hyundai Mobis are associated (or correlated) with Celltrion Pharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Celltrion Pharm has no effect on the direction of Hyundai Mobis i.e., Hyundai Mobis and Celltrion Pharm go up and down completely randomly.

Pair Corralation between Hyundai Mobis and Celltrion Pharm

Assuming the 90 days trading horizon Hyundai Mobis is expected to under-perform the Celltrion Pharm. But the stock apears to be less risky and, when comparing its historical volatility, Hyundai Mobis is 2.11 times less risky than Celltrion Pharm. The stock trades about -0.03 of its potential returns per unit of risk. The Celltrion Pharm is currently generating about 0.21 of returns per unit of risk over similar time horizon. If you would invest  5,250,000  in Celltrion Pharm on September 26, 2024 and sell it today you would earn a total of  990,000  from holding Celltrion Pharm or generate 18.86% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	95.65%
Values	Daily Returns

Hyundai Mobis  vs.  Celltrion Pharm

Hyundai Mobis

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Hyundai Mobis are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Hyundai Mobis may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Celltrion Pharm

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Celltrion Pharm has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pair Trading with Hyundai Mobis and Celltrion Pharm

The main advantage of trading using opposite Hyundai Mobis and Celltrion Pharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hyundai Mobis position performs unexpectedly, Celltrion Pharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Celltrion Pharm will offset losses from the drop in Celltrion Pharm's long position.

The idea behind Hyundai Mobis and Celltrion Pharm pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.